Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma
Clinical trial NCT05065047 · TERMINATED
Trial details
- NCT number
- NCT05065047
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-05
- Primary completion
- 2025-11-06
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.